Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Rheumatoid epitopes and CD4+ immunodominant regions of recombinant hepatitis B surface antigen.

Honorati MC, Facchini A.

J Rheumatol. 1999 Jul;26(7):1636. No abstract available.

PMID:
10405957
2.

Brief surface antigenemia in newborn infants vaccinated with hepatitis B vaccine.

Challapalli M, Slosar M, Vasa R, Cunningham DG.

Pediatr Infect Dis J. 1993 Oct;12(10):878-9. No abstract available.

PMID:
8284126
3.

Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy.

Cooper C, Mackie D.

Expert Rev Vaccines. 2011 Apr;10(4):417-27. doi: 10.1586/erv.10.162. Review.

PMID:
21506639
4.

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.

Joines RW, Blatter M, Abraham B, Xie F, De Clercq N, Baine Y, Reisinger KS, Kuhnen A, Parenti DL.

Vaccine. 2001 Sep 14;19(32):4710-9.

PMID:
11535321
5.

Antigens in hepatitis B vaccines.

Mital N.

Indian Pediatr. 2001 Jul;38(7):797. No abstract available.

PMID:
11463972
6.

Antibody responses to recombinant hepatitis B vaccines.

Hessel L, West DJ.

Vaccine. 2002 May 22;20(17-18):2164-5. No abstract available.

PMID:
12009268
7.

[Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1].

Chen XC, Zhou BP, Li MZ, Wang ZX, Wang HS, Zhang B, Tang W.

Zhonghua Gan Zang Bing Za Zhi. 2003 Mar;11(3):184-5. Chinese. No abstract available.

PMID:
12681075
8.

Prolonged Hepatitis B surface antigen positivity in Hepatitis B vaccine recipients.

Sharma S, Saini N, Arora L, Chawla Y, Duseja A.

Dig Liver Dis. 2006 Nov;38(11):860-1. Epub 2006 Aug 1. No abstract available.

PMID:
16884965
9.

Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin.

Torresi J.

Antivir Ther. 2008;13(3):337-40. No abstract available.

PMID:
18572745
10.

Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.

Carniel EF, Morcillo AM, Blotta MH, Da Silva MT, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, Vilela MM.

Vaccine. 2008 Jan 30;26(5):647-52. Epub 2007 Dec 7.

PMID:
18155811
11.

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.

Gruener NH, Gerlach TJ, Ulsenheimer A, Diepolder HM, Wierenga E, Zachoval R, Heeg M, Pape GR, Jung MC.

Vaccine. 2007 Jun 21;25(26):4960-6. Epub 2006 Dec 22.

PMID:
17466417
12.

[Humoral immune response of BALB/c mice immunized with chimer HBcAg proteins carrying the epitopes of surface hepatic B virus protein].

Veremeĭko TA, Lebedev LR, Chikaev NA, Il'ichev AA, Karpenko LI.

Vopr Virusol. 2007 Jan-Feb;52(1):40-5. Russian.

PMID:
17338233
13.

[Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].

Liu X, Yang G, Qiu B, Tian P.

Wei Sheng Wu Xue Bao. 2001 Oct;41(5):625-9. Chinese.

PMID:
12552813
14.

Nonresponders to hepatitis B vaccine.

Jenson HB.

Postgrad Med. 2000 Mar;107(3):97-8. No abstract available.

PMID:
10728138
15.

New vaccination strategies for low- and non-responders to hepatitis B vaccine.

Rendi-Wagner P, Wiedermann G, Stemberger H, Kollaritsch H.

Wien Klin Wochenschr. 2002 Mar 28;114(5-6):175-80. Review.

PMID:
12238305
17.
18.
19.

Transient hepatitis B antigenemia in hemodialysis patients following hepatitis B vaccination.

Kear TM, Wright LS.

ANNA J. 1996 Jun;23(3):331, 337. No abstract available.

PMID:
8716993
20.

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine.

Netter HJ, Woo WP, Tindle R, Macfarlan RI, Gowans EJ.

Vaccine. 2003 Jun 20;21(21-22):2692-7.

PMID:
12798605
Items per page

Supplemental Content

Write to the Help Desk